Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing

Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...

Полное описание

Библиографические подробности
Главные авторы:	Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils
Формат:	Статья
Язык:	English
Опубликовано:	Nature Portfolio 2024-08-01
Серии:	Communications Biology
Online-ссылка:	https://doi.org/10.1038/s42003-024-06659-8

Схожие документы

PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
по: S. De Taeye, и др.
Опубликовано: (2022-12-01)

A functional spleen contributes to afucosylated IgG in humans
по: Iwona Wojcik, и др.
Опубликовано: (2021-12-01)

Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
по: Mary Lopez-Perez, и др.
Опубликовано: (2025-01-01)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
по: Angela I. Schriek, и др.
Опубликовано: (2022-11-01)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
по: Angela I. Schriek, и др.
Опубликовано: (2022-05-01)

Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination
по: Mads Delbo Larsen, и др.
Опубликовано: (2021-10-01)

PP 8.5 – 00080 Fc-engineering of anti-HIV-1 antibodies and nanobodies to improve Fc mediated effector functions
по: A. Schriek, и др.
Опубликовано: (2022-12-01)

Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells
по: Alexandros Karampatzakis, и др.
Опубликовано: (2021-03-01)

Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.
по: Marloes Grobben, и др.
Опубликовано: (2024-12-01)

The Ligands for Human IgG and Their Effector Functions
по: Steven W. de Taeye, и др.
Опубликовано: (2019-04-01)

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
по: Thomas Sénard, и др.
Опубликовано: (2020-08-01)

Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
по: Karlijn van der Straten, и др.
Опубликовано: (2024-08-01)

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
по: Daniele Caracciolo, и др.
Опубликовано: (2021-02-01)

Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
по: Jeffrey C. Umotoy, и др.
Опубликовано: (2021-07-01)

FcγR Binding and ADCC Activity of Human IgG Allotypes
по: Steven W. de Taeye, и др.
Опубликовано: (2020-05-01)

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry
по: Steffen Lippold, и др.
Опубликовано: (2021-01-01)

Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry
по: Steffen Lippold, и др.
Опубликовано: (2019-10-01)

Differences in IgG afucosylation between groups with and without carotid atherosclerosis
по: Cuihong Tian, и др.
Опубликовано: (2024-11-01)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
по: Maryam Mehrabi, и др.
Опубликовано: (2021-09-01)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
по: Myrthe E. Sonneveld, и др.
Опубликовано: (2018-01-01)

Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody
по: Aaron Gupta, и др.
Опубликовано: (2023-05-01)

Targeting Tn-positive tumors with an afucosylated recombinant anti-Tn IgG
по: Yasuyuki Matsumoto, и др.
Опубликовано: (2023-03-01)

Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
по: Christoph Gstöttner, и др.
Опубликовано: (2022-09-01)

Understanding antibody-dependent enhancement in dengue: are afucosylated IgG1s a concern?
по: Teo, Andrew, и др.
Опубликовано: (2023)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
по: Andrew Teo, и др.
Опубликовано: (2023-03-01)

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?
по: Andrew Teo, и др.
Опубликовано: (2023-03-01)

Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimization
по: Bala Reddy Bheemareddy, и др.
Опубликовано: (2022-10-01)

Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model
по: David Falck, и др.
Опубликовано: (2022-12-01)

N-linked Fc glycosylation is not required for IgG-B-cell receptor function in a GC-derived B-cell line
по: Theresa Kissel, и др.
Опубликовано: (2024-01-01)

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation
по: Myrthe E. Sonneveld, и др.
Опубликовано: (2017-08-01)

Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates
по: Allyson Kwiatkowski, и др.
Опубликовано: (2020-01-01)

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccineesResearch in context
по: Julie Van Coillie, и др.
Опубликовано: (2023-01-01)

Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA binding affinity
по: Grayson Hatfield, и др.
Опубликовано: (2022-10-01)

Factors affecting IgG4-mediated complement activation
по: Nienke Oskam, и др.
Опубликовано: (2023-01-01)

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia
по: Laurène Pousse, и др.
Опубликовано: (2023-05-01)

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization
по: Judith Cruz Amaya, и др.
Опубликовано: (2023-06-01)

Trends in SPR Cytometry: Advances in Label-Free Detection of Cell Parameters
по: Richard B. M. Schasfoort, и др.
Опубликовано: (2018-10-01)

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
по: Myrthe L. Verburgh, и др.
Опубликовано: (2023-06-01)

Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties
по: Steffen Lippold, и др.
Опубликовано: (2019-10-01)

Antibodies and their receptors: different potential roles in mucosal defence
по: Rachel eHorton, и др.
Опубликовано: (2013-07-01)